To the Editor We read with interest the Viewpoint by Steinman and colleagues1 suggesting a reevaluation of appropriate use criteria for Mohs micrographic surgery (MMS) with respect to primary superficial basal cell carcinoma (sBCC). We must note that MMS is only 1 means of margin control of skin cancers, and perhaps the Viewpoint title would more accurately read “Reevaluation of Excisional Surgery for Primary Basal Cell Carcinoma.”